Åke Westin

1.4k total citations
17 papers, 1.1k citations indexed

About

Åke Westin is a scholar working on Physiology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Åke Westin has authored 17 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Physiology, 7 papers in Molecular Biology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Åke Westin's work include Smoking Behavior and Cessation (13 papers), Nicotinic Acetylcholine Receptors Study (7 papers) and Asthma and respiratory diseases (4 papers). Åke Westin is often cited by papers focused on Smoking Behavior and Cessation (13 papers), Nicotinic Acetylcholine Receptors Study (7 papers) and Asthma and respiratory diseases (4 papers). Åke Westin collaborates with scholars based in Sweden, Belgium and United States. Åke Westin's co-authors include Tobias Danielsson, Thórarinn Blöndal, G Gustavsson, Philip Tønnesen, E. Lunell, K.O. Fagerström, Lárus J. Gudmundsson, J A Stapleton, Mikael Franzon and Elbert D. Glover and has published in prestigious journals such as European Respiratory Journal, Clinical Pharmacology & Therapeutics and Addiction.

In The Last Decade

Åke Westin

17 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Åke Westin Sweden 13 943 309 295 220 176 17 1.1k
Anna Phillips‐Waller United Kingdom 11 1.1k 1.2× 160 0.5× 486 1.6× 245 1.1× 102 0.6× 15 1.3k
Joe Gitchell United States 15 791 0.8× 157 0.5× 315 1.1× 273 1.2× 41 0.2× 24 910
Eva Králíková Czechia 18 576 0.6× 167 0.5× 236 0.8× 136 0.6× 69 0.4× 89 996
Dunja Przulj United Kingdom 17 1.5k 1.5× 211 0.7× 603 2.0× 308 1.4× 123 0.7× 25 1.7k
Paula Lindgren United States 12 513 0.5× 78 0.3× 156 0.5× 148 0.7× 227 1.3× 19 763
Jessica Yingst United States 17 1.0k 1.1× 138 0.4× 392 1.3× 295 1.3× 47 0.3× 48 1.2k
Natalie Bisal United Kingdom 4 862 0.9× 96 0.3× 394 1.3× 183 0.8× 83 0.5× 5 993
Madeleine Lee United States 4 969 1.0× 92 0.3× 381 1.3× 220 1.0× 68 0.4× 4 1.1k
Susan Veldheer United States 19 1.0k 1.1× 139 0.4× 508 1.7× 288 1.3× 52 0.3× 62 1.4k
Wendy Bjornson United States 7 432 0.5× 99 0.3× 125 0.4× 112 0.5× 155 0.9× 9 557

Countries citing papers authored by Åke Westin

Since Specialization
Citations

This map shows the geographic impact of Åke Westin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Åke Westin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Åke Westin more than expected).

Fields of papers citing papers by Åke Westin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Åke Westin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Åke Westin. The network helps show where Åke Westin may publish in the future.

Co-authorship network of co-authors of Åke Westin

This figure shows the co-authorship network connecting the top 25 collaborators of Åke Westin. A scholar is included among the top collaborators of Åke Westin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Åke Westin. Åke Westin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Olsson, Per, Juan José Pérez Ruixo, Åke Westin, Anna Hansson, & P.A. Soons. (2020). Nicotine Population Pharmacokinetics in Healthy Smokers After Intravenous, Oral, Buccal and Transdermal Administration. Clinical Pharmacokinetics. 60(4). 541–561. 10 indexed citations
2.
Germovsek, Eva, Anna Hansson, Mats O. Karlsson, et al.. (2020). A Time‐to‐Event Model Relating Integrated Craving to Risk of Smoking Relapse Across Different Nicotine Replacement Therapy Formulations. Clinical Pharmacology & Therapeutics. 109(2). 416–423. 7 indexed citations
3.
Germovsek, Eva, Anna Hansson, Maria C. Kjellsson, et al.. (2019). Relating Nicotine Plasma Concentration to Momentary Craving Across Four Nicotine Replacement Therapy Formulations. Clinical Pharmacology & Therapeutics. 107(1). 238–245. 7 indexed citations
4.
Tonstad, Serena, et al.. (2014). Symptoms of Nicotine Toxicity in Subjects Achieving High Cotinine Levels During Nicotine Replacement Therapy. Nicotine & Tobacco Research. 16(9). 1266–1271. 4 indexed citations
5.
Rennard, Stephen I., Elbert D. Glover, Scott J. Leischow, et al.. (2006). Efficacy of the nicotine inhaler in smoking reduction: A double-blind, randomized trial. Nicotine & Tobacco Research. 8(4). 555–564. 63 indexed citations
6.
Bohadana, Abraham, Fredrik Nilsson, Åke Westin, Nadine Martinet, & Yves Martinet. (2005). Smoking cessation—but not smoking reduction—improves the annual decline in FEV1 in occupationally exposed workers. Respiratory Medicine. 100(8). 1423–1430. 13 indexed citations
7.
Batra, Anil, et al.. (2005). Smoking reduction treatment with 4-mg nicotine gum: A double-blind, randomized, placebo-controlled study. Clinical Pharmacology & Therapeutics. 78(6). 689–696. 70 indexed citations
8.
Tønnesen, Philip, et al.. (2005). Effects of smoking cessation and reduction in asthmatics. Nicotine & Tobacco Research. 7(1). 139–148. 84 indexed citations
9.
Glover, Elbert D., et al.. (2005). Developmental History of the Glover-Nilsson Smoking Behavioral Questionnaire. American Journal of Health Behavior. 29(5). 443–455. 46 indexed citations
10.
Glover, Elbert D., et al.. (2005). Developmental history of the Glover-Nilsson smoking behavioral questionnaire.. PubMed. 29(5). 443–55. 49 indexed citations
11.
12.
Bolliger, Chris T., Jean-Pierre Zellweger, Tobias Danielsson, et al.. (2002). Influence of long-term smoking reduction on health risk markers and quality of life. Nicotine & Tobacco Research. 4(4). 433–439. 70 indexed citations
13.
Eliasson, Björn, et al.. (2001). Effect of smoking reduction and cessation on cardiovascular risk factors. Nicotine & Tobacco Research. 3(3). 249–255. 91 indexed citations
14.
15.
Blöndal, Thórarinn, Mikael Franzon, & Åke Westin. (1997). A double-blind randomized trial of nicotine nasal spray as an aid in smoking cessation. European Respiratory Journal. 10(7). 1585–1590. 62 indexed citations
16.
Fagerström, K.O., et al.. (1997). Aiding reduction of smoking with nicotine replacement medications: hope for the recalcitrant smoker?. Tobacco Control. 6(4). 311–316. 116 indexed citations
17.
Puska, Pekka, et al.. (1995). Combined use of nicotine patch and gum compared with gum alone in smoking cessation - a clinical trial in North Karelia. Tobacco Control. 4(3). 231–235. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Phillips‐Waller Breakdown of academic impact, for papers by Joe Gitchell Breakdown of academic impact, for papers by Eva Králíková Breakdown of academic impact, for papers by Dunja Przulj Breakdown of academic impact, for papers by Paula Lindgren Breakdown of academic impact, for papers by Jessica Yingst Breakdown of academic impact, for papers by Natalie Bisal Breakdown of academic impact, for papers by Madeleine Lee Breakdown of academic impact, for papers by Susan Veldheer Breakdown of academic impact, for papers by Wendy Bjornson
Rankless by CCL
2026